本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Artelo Biosciences, Inc.

0.9538
-0.0162-1.67%
盤後0.8835-0.0703-7.37%19:49 EDT
成交量:12.55萬
成交額:11.57萬
市值:307.86萬
市盈率:-0.31
高:0.9600
開:0.9103
低:0.8808
收:0.9700
資料載入中...
2025/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/17

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/12

SEC問詢函

Form CORRESP - Correspondence
2023/07/04

重要事件披露

Form 8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/21

重要事件披露

8-K - Current report
2023/04/21

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report